Concourse Financial Group Securities, Inc. Cerus Corp Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CERS
# of Institutions
149Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$36.4 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$35.6 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$19.2 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$15.7 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $324M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...